ASHLEY REINHARD: Open Payments
NPI 1336491513 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 35 payments from 14 companies in 2025. Trend: 2023 $2,062 · 2024 $1,170 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $232 |
| ABBVIE INC. | 9 | $140 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $51 |
| Incyte Corporation | 2 | $47 |
| Galderma Laboratories, L.P. | 3 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: Rhapsido, COSENTYX, RINVOQ, Sotyktu, OPZELURA, SKYRIZI, ILUMYA, DUPIXENT.
Industry payments across MO — which companies pay providers there.
